Propentofylline prevents neuronal dysfunction induced by infusion of anti-nerve growth factor antibody into the rat septum

Atsumi Nitta, Yoshiko Ogihara, Joji Onishi, Takaaki Hasegawa, Shoei Furukawa, Toshitaka Nabeshima

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

We have reported that the continuous infusion of anti-nerve growth factor (NGF) monoclonal antibody into the septum of rats produces neuronal dysfunction in the cholinergic system. Propentofylline has potent stimulatory effects on NGF synthesis/secretion in mouse astrocytes in vitro. To investigate the pharmacological effects of propentofylline, we used an animal model of dementia in which anti-NGF antibody was infused into the septum for 16 days via a mini-osmotic pump. The rats were treated with propentofylline orally once a day throughout the period during which performance in learning and memory tasks was observed. In the vehicle-treated dementia rats, learning and memory ability and choline acetyltransferase and cholinesterase activity were reduced compared to values in the control rats. The administration of propentofylline prevented the decreased learning capacity and the deficit in cholinergic marker enzyme activities. These results suggest that the use of NGF stimulators may provide a new approach to the treatment of dementia.

Original languageEnglish
Pages (from-to)1-6
Number of pages6
JournalEuropean Journal of Pharmacology
Volume307
Issue number1
DOIs
Publication statusPublished - 20-06-1996
Externally publishedYes

Fingerprint

Nerve Growth Factor
Dementia
Antibodies
Learning
Cholinergic Agents
Aptitude
Choline O-Acetyltransferase
Cholinesterases
Astrocytes
Animal Models
Monoclonal Antibodies
Pharmacology
propentofylline
Enzymes

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

Nitta, Atsumi ; Ogihara, Yoshiko ; Onishi, Joji ; Hasegawa, Takaaki ; Furukawa, Shoei ; Nabeshima, Toshitaka. / Propentofylline prevents neuronal dysfunction induced by infusion of anti-nerve growth factor antibody into the rat septum. In: European Journal of Pharmacology. 1996 ; Vol. 307, No. 1. pp. 1-6.
@article{36c620bbb8ac4388955bcc4125af1e19,
title = "Propentofylline prevents neuronal dysfunction induced by infusion of anti-nerve growth factor antibody into the rat septum",
abstract = "We have reported that the continuous infusion of anti-nerve growth factor (NGF) monoclonal antibody into the septum of rats produces neuronal dysfunction in the cholinergic system. Propentofylline has potent stimulatory effects on NGF synthesis/secretion in mouse astrocytes in vitro. To investigate the pharmacological effects of propentofylline, we used an animal model of dementia in which anti-NGF antibody was infused into the septum for 16 days via a mini-osmotic pump. The rats were treated with propentofylline orally once a day throughout the period during which performance in learning and memory tasks was observed. In the vehicle-treated dementia rats, learning and memory ability and choline acetyltransferase and cholinesterase activity were reduced compared to values in the control rats. The administration of propentofylline prevented the decreased learning capacity and the deficit in cholinergic marker enzyme activities. These results suggest that the use of NGF stimulators may provide a new approach to the treatment of dementia.",
author = "Atsumi Nitta and Yoshiko Ogihara and Joji Onishi and Takaaki Hasegawa and Shoei Furukawa and Toshitaka Nabeshima",
year = "1996",
month = "6",
day = "20",
doi = "10.1016/0014-2999(96)00133-1",
language = "English",
volume = "307",
pages = "1--6",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1",

}

Propentofylline prevents neuronal dysfunction induced by infusion of anti-nerve growth factor antibody into the rat septum. / Nitta, Atsumi; Ogihara, Yoshiko; Onishi, Joji; Hasegawa, Takaaki; Furukawa, Shoei; Nabeshima, Toshitaka.

In: European Journal of Pharmacology, Vol. 307, No. 1, 20.06.1996, p. 1-6.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Propentofylline prevents neuronal dysfunction induced by infusion of anti-nerve growth factor antibody into the rat septum

AU - Nitta, Atsumi

AU - Ogihara, Yoshiko

AU - Onishi, Joji

AU - Hasegawa, Takaaki

AU - Furukawa, Shoei

AU - Nabeshima, Toshitaka

PY - 1996/6/20

Y1 - 1996/6/20

N2 - We have reported that the continuous infusion of anti-nerve growth factor (NGF) monoclonal antibody into the septum of rats produces neuronal dysfunction in the cholinergic system. Propentofylline has potent stimulatory effects on NGF synthesis/secretion in mouse astrocytes in vitro. To investigate the pharmacological effects of propentofylline, we used an animal model of dementia in which anti-NGF antibody was infused into the septum for 16 days via a mini-osmotic pump. The rats were treated with propentofylline orally once a day throughout the period during which performance in learning and memory tasks was observed. In the vehicle-treated dementia rats, learning and memory ability and choline acetyltransferase and cholinesterase activity were reduced compared to values in the control rats. The administration of propentofylline prevented the decreased learning capacity and the deficit in cholinergic marker enzyme activities. These results suggest that the use of NGF stimulators may provide a new approach to the treatment of dementia.

AB - We have reported that the continuous infusion of anti-nerve growth factor (NGF) monoclonal antibody into the septum of rats produces neuronal dysfunction in the cholinergic system. Propentofylline has potent stimulatory effects on NGF synthesis/secretion in mouse astrocytes in vitro. To investigate the pharmacological effects of propentofylline, we used an animal model of dementia in which anti-NGF antibody was infused into the septum for 16 days via a mini-osmotic pump. The rats were treated with propentofylline orally once a day throughout the period during which performance in learning and memory tasks was observed. In the vehicle-treated dementia rats, learning and memory ability and choline acetyltransferase and cholinesterase activity were reduced compared to values in the control rats. The administration of propentofylline prevented the decreased learning capacity and the deficit in cholinergic marker enzyme activities. These results suggest that the use of NGF stimulators may provide a new approach to the treatment of dementia.

UR - http://www.scopus.com/inward/record.url?scp=0030594569&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030594569&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(96)00133-1

DO - 10.1016/0014-2999(96)00133-1

M3 - Article

C2 - 8831096

AN - SCOPUS:0030594569

VL - 307

SP - 1

EP - 6

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1

ER -